Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Experian Plc LSE:EXPN London Ordinary Share GB00B19NLV48 ORD USD0.10
  Price Change % Change Share Price Shares Traded Last Trade
  -31.00 -1.07% 2,857.00 136,960 10:20:32
Bid Price Offer Price High Price Low Price Open Price
2,855.00 2,857.00 2,893.00 2,849.00 2,886.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 4,783.04 1,100.68 96.98 27.8 26,309
Last Trade Time Trade Type Trade Size Trade Price Currency
10:20:45 O 322 2,856.276 GBX

Experian (EXPN) Latest News

More Experian News
Experian Investors    Experian Takeover Rumours
Smart Money!
EXPN is a large holding in the following funds:
 Fund  Percentage of Fund  Last Updated 
 EUROPEAN OPPORTUNITIES TRUST PLC 9.70% 2022-12-31

Experian (EXPN) Discussions and Chat

Experian Forums and Chat

Date Time Title Posts
16/11/202215:02Experian1,629
02/2/202220:32How long before this gets taken over ?282
23/6/201413:35TipTv discusses Experian PLC-
19/11/200811:51Experian511
17/10/200706:48EXPERIAN45

Add a New Thread

Experian (EXPN) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
10:20:462,856.283229,197.21O
10:20:452,856.113239,225.23O
10:20:082,857.00701,999.90AT
10:20:082,857.0011314.27AT
10:20:002,856.00691,970.64AT
View all Experian trades in real-time

Experian (EXPN) Top Chat Posts

Top Posts
Posted at 27/1/2023 08:20 by Experian Daily Update
Experian Plc is listed in the Support Services sector of the London Stock Exchange with ticker EXPN. The last closing price for Experian was 2,888p.
Experian Plc has a 4 week average price of 2,796p and a 12 week average price of 2,633p.
The 1 year high share price is 3,222p while the 1 year low share price is currently 2,242p.
There are currently 920,876,004 shares in issue and the average daily traded volume is 2,356,746 shares. The market capitalisation of Experian Plc is £26,364,679,994.52.
Posted at 10/11/2022 15:19 by imperial3
Why the sudden jump in the share price? Anyone know?
Posted at 26/8/2022 10:03 by imperial3
The shares have been weak for quite some time now.I would have thought all the bad news has been priced in.Yet they still continue to decline.I wonder what the floor price will eventually be?
Posted at 23/5/2022 16:14 by imperial3
Another positive blue end to the day.A share buy back programme in place helps as well.
Posted at 18/5/2022 15:33 by imperial3
During the past 6 months or so,the share price has been in steady decline.Today's results have hammered the share price.In fact,I perceive they were good,yet the market thought otherwise.What else can the company do,to turn this round?
Posted at 18/5/2022 08:46 by ram376s
Still good feeling for this share .GDR primed for possible multi bag . New test . 300 nurses to be trained .
Posted at 13/2/2022 19:13 by essentialinvestor
Mentioned this as put EXPN back on a watchlist late last week
and wondered if anyone had additional information.

As with the NHS, very large backlogs have developed in UK court cases
so I assume it has not yet reached this stage.

Posted at 12/2/2022 11:56 by imperial3
That being the case,why the share drop recently?
Posted at 11/2/2022 16:40 by essentialinvestor
Https://www.dailymail.co.uk/news/article-9307429/Almost-adult-England-Wales-share-34-BILLION-High-Court-case.html


As above.

Posted at 14/1/2022 22:09 by mjneish
Trying to figure out why the price has fallen so much. Admittedly I know nothing about this company, but I had a quick look at the figures to get a rough idea.

Benchmark EPS was 103.1 cents in 2021.

In their half-year report for the current year it was 61.7 cents, so assuming that they double this in the full year to say 120 cents, which is about 88p, this would leave them with a PE ratio of 35.

This is hardly cheap for a company that's growing revenues at around 15% per year.

Of course there's more to it than this, but at first glance the shares look expensive.

Could someone enlighten me? Thanks.

Posted at 17/11/2021 07:31 by hotfinance14
Superb half year results:

Brian Cassin, Chief Executive Officer, commented:

"We had a very good first half performance with total revenue growth of 23% at actual exchange rates, 21% at constant exchange rates and organic revenue growth of 16%. Benchmark earnings per share also progressed strongly, up 30% for the half (at constant exchange rates). Consumer Services has seen standout growth, and our B2B businesses continue to perform very well. We expect progress to continue, and for the full year, we now expect organic revenue growth in the range of 11-13%, total revenue growth of 15-17% and strong EBIT margin accretion, all at constant exchange rates."

Experian share price data is direct from the London Stock Exchange
Your Recent History
LSE
EXPN
Experian
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230127 10:35:48